Abstract
Chemoprevention is the use of natural or synthetic compounds in order to reverse, suppress or prevent the carcinogenic process. Among the many pathways dysregulated during the carcinogenic process, cyclooxygenase-2 (Cox2) seems to be one of the most promising pathways to target in order to achieve chemopreventive and anticancer effects. Indeed, Cox2 overexpression contributes to the carcinogenic by at least 5 different mechanisms including transformation of procarcinogens on carcinogens, pro-inflammatory and immunomodulatory effect, resistance to apoptosis, angiogenesis and invasion progression... This review will focus on the rationale and the ongoing research areas related to chemopreventive approaches targeting Cox2.
MeSH terms
-
Animals
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Anticarcinogenic Agents / therapeutic use*
-
Aspirin / therapeutic use
-
Colorectal Neoplasms / enzymology
-
Colorectal Neoplasms / prevention & control
-
Cyclooxygenase 2
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors / therapeutic use*
-
Female
-
Humans
-
Male
-
Membrane Proteins
-
Mice
-
Neoplasm Proteins / antagonists & inhibitors
-
Neoplasm Proteins / metabolism
-
Neoplasms / enzymology
-
Neoplasms / prevention & control*
-
Prostaglandin-Endoperoxide Synthases / metabolism
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Anticarcinogenic Agents
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors
-
Membrane Proteins
-
Neoplasm Proteins
-
Cyclooxygenase 2
-
PTGS2 protein, human
-
Prostaglandin-Endoperoxide Synthases
-
Aspirin